HassanEl ChebibMDFAAP

Pediatric Infectious Disease • Hartford, CT

Attending Physician At Connecticut Children's; Associate Professor at University of Connecticut School of Medicine; Program Director of the pediatric infectious disease fellowship program at University of Connecticut; Adjunct Assistant Professor of Pediatrics at Frank Netter School of Medicine at Quinnipiac University

Join to view full profile

Dr. El Chebib is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. El Chebib's full profile

Already have an account?

Office
282 Washington St
Hartford, CT 06106
Phone+1 860-545-9490

Fax+1 860-545-9371

Summary

Pediatric Infectious Disease specialist with experience in immunology and demonstrated history of working in the hospital & health care industry. Skilled in Epidemiology, Molecular Biology, Cell Culture, Healthcare, and Clinical Research. Strong healthcare services professional with a M.D. focused in Medicine from American University of Beirut.

Education & Training

SUNY Upstate Medical UniversityChief Residency, Pediatrics, 2019 - 2019
SUNY Upstate Medical UniversityResidency, Pediatrics, 2017 - 2019
SUNY Upstate Medical UniversityFellowship, Pediatric Infectious Diseases, 2014 - 2017
American University of Beirut Faculty of MedicineClass of 2007
American University of BeirutBS, Biology, 1998 - 2002

Certifications & Licensure

CT State Medical License 2019 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases
American Board of PediatricsPediatric Infectious Diseases
Collaborative Institutional Training Initiative ProgramCITI Program Certification
ECFMGECFMG certificate

Awards, Honors, & Recognition

Excellence in Teaching in a Subspecialty University of Connecticut School of Medicine, 2022, 2024
Star of the week Connecticut Children's Medical Center Executive Team, 2020
Infectious diseases society of America Antimicrobial Stewardship Center of Excellence Designation Infectious Diseases Society of America, 2020
Didactic teaching award Connecticut Children's, 2020
Healthcare Hero Connecticut Children's, 2020
Didactic teaching award University of Connecticut School of Medicine, 2020
IDSA Travel Award IDSA, 2016
Best poster presentation IFMSA, 2011
Best poster presentation IFMSA SCORE, 2009
Join now to see all

Publications & Presentations

PubMed

A Case Study of a Rapidly Progressive Cellulitis of the Penis and Scrotum in a Two-Month-Old Infant.
Michael A Larsen, Alexander H Hogan, Hassan El Chebib
Cureus. 2022-12-01
23 citations
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients.
Daniel E. Dulek, Robert C. Fuhlbrigge, Alison C Tribble, James A. Connelly, Michele M Loi
Journal of the Pediatric Infectious Diseases Society. 2020-12-31
6 citations
Anaerobic Necrotizing Pneumonia: Another Potential Life-threatening Complication of Vaping?
Hassan El Chebib, Kiah McArthur, Michelle Gorbonosov, Joseph B. Domachowske
Pediatrics. 2020-04-01

Books/Book Chapters

Manson's Tropical Diseases
Chapter: ndemic Spirochetal Diseases, including Yaws, Lyme Disease and Leptospirosis
Hassan El ChebibElsevier2023

Abstracts/Posters

Exploring the Relationship Between SGA and TREC Counts in Neonatal State-Mandated SCID Screening Tests
Humza Zaidi BA, BS, Brooke Onwenu BS, Hassan El Chebib MD, Naveed Hussain MD, Connecticut Children’s 4th Annual Research Symposium,, Glastonbury, CT, 11/2024
Outpatient Antimicrobial Stewardship Program Pilot: Targeting Pediatric Healthcare Providers in the Community
Waynik I, El Chebib H, Girotto JE, Krol DM, Pediatric Academic Societies Meeting, Toronto, Canada, 5/2024
The Use of Central Nervous System Stimulants to Treat Long COVID Fatigue in Pediatric Patients
Zulfi A, Gomez N, Zempsky W, Michelow I, El Chebib H, Hong G, Girotto J, Theriault C., Pediatric Academic Societies Meeting, Toronto, Canada, 5/2024
Correspondence Analysis in Multivariate Symptomology: Visualizing Symptom Clusters and Reported Conditions in COVID Related Patients
Brimacombe M, Hogan AH, El Chebib H, Herbst KW, Lynes MA, Salazar JC, Pediatric Academic Societies Meeting, Toronto, Canada, 5/2024
Exploring the Relationship Between SGA and TREC Counts in Neonatal State-Mandated SCID Screening Tests.
Humza Zaidi BA, BS, Brooke Onwenu BS, Hassan El Chebib MD, Naveed Hussain MD, New England Perinatal Society Meeting, Newport, RI, 3/2024
Multivariate Analysis of Highly Correlated Immunological Biomarker Variables: Dimension Reduction and Predictive Models
Brimacombe, Michael, Hogan, Alexander H, El Chebib, Hassan, Herbst, Katherine W, López-Medina, Eduardo L, De La Cruz, Catalina, Jadhav, Aishwarya , Lee, William T , La..., 3rd Annual Research Symposium, Hartford, CT, 11/2023
Outpatient antimicrobial stewardship: targeting pediatric healthcare providers in the community
Ilana Waynik, Hassan El Chebib, Kevhanna Whyte, Jennifer Girotto, David Krol, 3rd Annual Research Symposium, Hartford, CT, 11/2023
Outpatient Antimicrobial Stewardship: Targeting Pediatric Healthcare Providers in the Community
Kevhanna Whyte, Ilana Waynik, Hassan El Chebib, Jennifer Girotto, David Krol, 9th Illuminations Conference, Hartford, CT, 6/2023
Defining Clinical Phenotypes of COVID Viral Infections and Post-Viral Syndromes.
Christopher L. Carroll, Alexander H. Hogan, Katherine W. Herbst, Celina Porcaro, Noah Schulman, Hassan El Chebib, Juan C. Salazar, Pediatric Academic Societies (PAS) Meeting, Denver, CO, 4/2022
Creation and Implementation of a Standardized Antimicrobial Use and Sepsis Evaluation Guideline across a Regional Network of NICUs
Alaina Pyle, Usha Prasad, Nancy Louis, Jennifer E Girotto, Hassan El Chebib, J. Leslie Knod, Brett Citarella, David Sink, Allison Sadowski, and Annmarie Golioto, Pediatric Academic Societies (PAS) Meeting, Denver, CO, 4/2022
Neutrophil activation in infants hospitalized with severe respiratory viral infections.
El Chebib, H., Bonville, CA, Domachowske, JB and Suryadevara, M., Pediatric Research Day, Syracuse, NY, 4/2017
Neutrophil activation in infants hospitalized with severe respiratory viral infections.
El Chebib, H., Bonville, CA., Domachowske, JB., & Suryadevara, M., Annual joint meeting of the Infectious Disease Society of America, Society for Healthcare Epidemiology of America, the HIV Medical Association and the Pediatric Infectious Diseases Society during the ID week, New Orleans, LA, 10/2016
Neutrophil activation in infants hospitalized with severe respiratory viral infections
• El Chebib, H., Bonville, CA , Domachowske, JB and Suryadevara, M., Open Forum Infectious Diseases, 2016
Influence of religious affiliation and school tuition on school immunization exemptions in California
Shaw J, DeNicola E, El Chebib H, Mehta M, Bednarczyk R, Nadeau J, Desemone C, McNutt L, Eastern Pediatric Academic Societies meeting, Philadelphia, PA, 3/2015
Exogenous Galactosylceramide Corrects Growth and Apoptotic Defects in Human CLN3-Deficient Cells and Behavioral Deficits in CLN3Δex7/8 Knock-in Male Mice by Lowering C...
El Chebib, H., Harati, H, Noutsi, B, ElMaoued, A, Cotman, S and Boustany RM, Second Kamal A. Shair Central Research Science Laboratory Research Conference, Beirut, Lebanon, 4/2014
Exogenous Galactosylceramide Corrects Growth and Apoptotic Defects in Human CLN3- Deficient Cells and Behavioral Deficits in CLN3Δex7/8 Knock-in Male Mice by Lowering ...
El Chebib H, Harati H, Noutsi B, ElMaoued A, Cotman S, Boustany RM, Standing Committee on Research Exchange as part of the International Federation of Medical Students’ Association – Research Day, Beirut, Lebanon, 4/2011
CLN3 knockdown impacts galactosyl ceramide traffic in mouse brain and human neuronal precursor cells
El Tamer M, El Chebib H, Noutsi B, Rusyn E, Cotman S, Boustany RM, 12th International Congress on Neuronal Ceroid Lipofuscinosis, Hamburg, Germany, 6/2009
CLN3 knockdown impacts galactosyl ceramide traffic in mouse brain and human neuronal precursor cells
El Tamer M, El Chebib H, Noutsi B, Rusyn E, Cotman S, Boustany, RM, Standing Committee on Research Exchange as part of the International Federation of Medical Students’ Association - Research Day, Beirut, Lebanon, 4/2009
Join now to see all

Lectures

HIV: A Pediatric Perspective.
Farmington, CT - 11/2024
Tick, Mosquito & Other Arthropod Related Diseases
Danbury, CT - 10/2024
Kawasaki Disease and Periodic Fever Syndromes
Farmington, CT - 10/2024
Infection Control
Hartford, CT - 9/2024
Intro to Pediatric Infectious Diseases
Farmington, CT - 9/2024
Intro to Pediatric Infectious Diseases
Farmington, CT - 5/2024
Outpatient Antimicrobial Stewardship: How to Incorporate into a Busy Practice
Hartford, CT - 4/2024
Intro to Pediatric Infectious Diseases
Farmington, CT - 2/2024
Kawasaki Disease and Periodic Fever Syndromes
Farmington, CT - 10/2023
Toxin mediated disease
Hartford, CT - 10/2023
HIV: A Pediatric Perspective
Farmington, CT - 9/2023
Immune Deficiencies in Children - Case Review
Hartford, CT - 9/2023
Sexually Transmitted Infections
Hartford, CT - 8/2023
Intro to Pediatric Infectious Diseases
Farmington, CT - 8/2023
Bk virus infection. Solid Organ Transplant M&M
Hartford, CT - 8/2023
Morbidity and mortality joint conference with pediatric hematology/oncology
Hartford, CT - 6/2023
Pneumonia: Causes and Complications
Hartford, CT - 6/2023
Intro to Pediatric Infectious Diseases
Farmington, CT - 5/2023
Unexplained fevers: An ID perspective
Hartford, CT - 2/2023
Immunology lecture series
Farmington, CT - 9/2022
Kawasaki Disease
Farmington, CT - 9/2022
Intro to Pediatric Infectious Diseases
Farmington, CT - 9/2022
HIV: A Pediatric Perspective
Hartford, CT - 9/2022
Lyme Disease: An Update and Overview
Hartford, CT - 5/2022
Youth HIV/AIDS Awareness Day Conference.
Hartford, CT - 4/2022
Join now to see all

Press Mentions

Work of Postdoctoral Students, Fellows and Medical Residents Spotlighted on Research Day March 1November 22nd, 2011
Doctor Says Fight is Not Finished on Measle VaccinationSeptember 8th, 2020
Ask the ExpertsSeptember 8th, 2020
Join now to see all

Grant Support

Outpatient Antimicrobial Stewardship in Pediatrics: Targeting Healthcare Providers in the Community.Pfizer2021–2023

Committees

Pediatric infectious disease physician member, Combined adult and pediatric infectious disease committee 2021 - Present
Infectious disease physician member, COVID-19 Vaccine Task Force 2021 - Present
Infectious disease physician member, Clinical pathway improvement committee 2020 - Present
Infectious disease physician member, Antimicrobial stewardship in the neonatal intensive care unit work group 2020 - Present
Infectious disease physician member, Clinical Effectiveness Committee 2020 - Present
Infectious disease physician member, Educational Leadership Committee 2020 - Present
Infectious disease physician member, Multisystem Inflammatory Syndrome in Children Task Force 2020 - Present
Associate program director, Fellowship Program Directors Committee 2020 - Present
Infectious disease physician member, Clinical Competency Committee 2020 - Present
Associate director, Pediatric infectious disease fellowship program evaluation committee 2020 - Present
Infectious disease physician member, Coronavirus disease-19 Connecticut Children's employee infection control, testing and return to work task force 2020 - Present
Infectious disease physician member, Coronavirus disease-19 guideline task force 2020 - Present
Infectious disease physician member, Pediatric pharmacy and therapeutic committee 2020 - Present
Infectious disease physician member, Pediatric infectious disease outpatient committee on improving healthcare delivery 2020 - Present
Infectious disease physician member, Antimicrobial stewardship committee 2020 - Present
Infectious disease physician member, Cytomegalovirus prevention and treatment guidelines for solid organ pediatric transplant in clinical practice 2020 - 2020
Infectious disease physician member, Pediatric pharmacy residency selection committee 2020 - 2020
Pediatric infectious disease member, Influenza immunization rates improvement in hospitalized pediatric patients 2016 - 2017
Pediatric infectious disease member, Pediatric infection control committee 2016 - 2017
Pediatric infectious disease member, Pediatric subcommittee of pharmaceutical and therapeutics committee 2016 - 2017
Project leader, Solid organ pre-transplant workup protocol in the donor and recipient patients 2015 - 2017
Project leader, Hepatitis B vaccination rates improvement in pediatric patients with HIV 2015 - 2017
Pediatric infectoius disease member, Pediatric antimicrobial stewardship committee 2014 - 2019
Pediatric infectious disease member, Pediatric central line associated blood stream infections quality improvement committee 2014 - 2017
Pediatric member and representative, Lebanese Order of Physicians’ Pediatric committee for improving residency programs 2011 - 2014

Research History

Primary investigatorValidation of osteoarticular infection clinical pathway and collection of pathogen and host samples for further identification and classification of extent of disease2024 - Present
Co-investigatorThe Use of Central Nervous System Stimulants to Treat Long COVID Fatigue in Pediatric Patients2023 - 2024
Co-investigatorUtility of Intraoperative Microbiological Cultures in Children with Complicated Appendicitis2023 - Present
Co-investigatorExploring the Relationship Between SGA and TREC Counts in Neonatal SCID Screens2023 - Present
Co-investigatorClinical Manifestations and Diagnostic Study Findings Associated with Lyme Carditis in Youth2023 - Present
Co-investigatoryA Multi-Center Observational Study: The RECOVER Post Acute Sequelae of SARS-CoV-2 (PASC) Pediatric Cohort Study2022 - Present
Co-investigatorReview of Connecticut Rabies Post-Exposure Prophylaxis: An 8 Year Review at an Academic Medical Center2022 - Present
Co-investigatorExpanded Access IND Protocol: Use of Tecovirimat (TPOXX) for Treatment of Human Non-Variola Orthopoxvirus Infections in Adults and Children2022 - Present
Co-investigatorObservational Study of Oral Doxycycline for the Treatment of Childhood Lyme Meningitis2022 - Present
Co-investigatorIdentifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)2021 - Present
Co-investigatorSARS-CoV-2 and Viral Infections Repository2020 - Present
Co-investigatorPatients Under Investigation for Coronavirus Disease 2019 (PUI) Repository2020 - Present
Co-investigatorA multi-center study to describe the epidemiology, clinical presentation, and outcomes of pediatric patients with COVID-19 across the United States2020 - Present
Primary investigatorOutpatient Antimicrobial Stewardship Project2022 - 2023
Primary InvestigatorA Phase 2/3, Interventional Safety, Pharmacokinetics, and Efficacy, Open-Label, Multi-Center, Single-Arm Study to Investigate Orally Administered PF-07321332 (Nirmatrelvir)/Ritonavir in Nonhospitalized Symptomatic Pediatric Participants with COVID-19 who are at Risk of Progression to Severe Disease2022 - 2023
Primary investigatorSafety and immunogenicity study of VLA15, a multivalent recombinant OSPA based vaccine candidate against Lyme Borreliosis: a randomized, controlled, observer-blind phase 2 study in a healthy pediatric and adult study population2021 - 2021
Co-investigatorExpanded Access IND Program to Provide Stamaril Vaccine to Persons in the United States for Vaccination Against Yellow Fever2020 - 2021
Sub-investigatorA phase 3, multicenter, open-label, randomized, comparator controlled trial of the safety and efficacy of dalbavancin versus active comparator in pediatric subjects with acute bacterial skin and skin structure infections. Sponsor: Allergan.2017 - 2017
Sub-investigatorClinical Performance of the Diassess Influenza A and B Test. Sponsor: Diassess.2017 - 2017
Sub-investigatorA Prospective Study to Assess the Pediatric Respiratory Syncytial Virus (RSV) Electronic Severity and Outcome Rating System (PRESORS) and Clinical Endpoints in Neonates, Infants, and Children less than or equal to 36 Months of Age Hospitalized with RSV Infection. Sponsor: Janssen.2017 - 2017
Sub-investigatorA Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13TM in Healthy Infants. Sponsor: Merck.2017 - 2017
Sub-investigatorA Phase 3, Randomized, Observer-Blind, Placebo- Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a RSV F Nanoparticle Vaccine with Aluminum in Healthy Third-Trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies. Sponsor: GSK2016 - 2017
Sub-investigatorA Phase 1/2, randomized, observer-blind, controlled, multi- center, dose-escalation study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on the RSV viral proteins encoded by chimpanzee derived adenovector. Sponsor: Glaxosmithkline2016 - 2017
Co-investigatorA single-center in vitro study to evaluate the level of expression of CD11b in neutrophils of children less than 2 years of age with viral respiratory tract infections. Partial sponsors: GlaxoSmithKline and Clark Foundation as part of State University of New York Upstate Medical University Hospital.2015 - 2017
Sub-investigatorA retrospective and prospective chart review of disease markers and treatment measures in pediatric Hepatitis A, B and C patients to identify consistent disease parameters for use in clinical management. Sponsor: Intramural as part of State University of New York Medical University Hospital.2014 - 2017
Sub-investigatorA phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a human monoclonal antibody, REGN2222, for the prevention of medically attended RSV infection in preterm infants. Sponsor: Regeneron.2015 - 2016
Sub-investigatorA phase 1b/2a randomized, double-blind, placebo- controlled, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of MEDI8897, a monoclonal antibody with an extended half-life against respiratory syncytial virus, in healthy preterm infants. Sponsor: Medimmune.2014 - 2016
Sub-investigatorA phase III, obersver-blind, randomized, controlled, multi-center study to evaluate the immunogenicity and safety of GSK biologicals’ quadrivalent influenza vaccine candidate compared to Sanofi Pasteur’s quadrivalent influenza vaccine Fluzone quadrivalent, administered intramuscularly. Sponsor: GSK2014 - 2015
Research fellowGalactosyl ceramide supplementation of CLN3 knock down mice. Sponsor: Dubai Harvard Foundation for Medical Research.2008 - 2011